PT  - JOURNAL ARTICLE
AU  - Ketan R Bulsara
AU  - Murat Günel
AU  - Sepideh Amin-Hanjani
AU  - Peng Roc Chen
AU  - E Sander Connolly
AU  - Robert M Friedlander
TI  - Results of a national cerebrovascular neurosurgery survey on the management of cerebral vasospasm/delayed cerebral ischemia
AID  - 10.1136/neurintsurg-2014-011223
DP  - 2015 Jun 01
TA  - Journal of NeuroInterventional Surgery
PG  - 408--411
VI  - 7
IP  - 6
4099  - http://jnis.bmj.com/content/7/6/408.short
4100  - http://jnis.bmj.com/content/7/6/408.full
SO  - J NeuroIntervent Surg2015 Jun 01; 7
AB  - Objective Following aneurysmal subarachnoid hemorrhage, cerebral vasospasm/delayed cerebral ischemia accounts for significant morbidity and mortality. In this paper we provide the first glimpse of actual practice in the management of cerebral vasospasm in the USA. Methods All active members of the Joint American Association of Neurological Surgeons (AANS)/Congress of Neurological Surgeons (CNS) Cerebrovascular Section were emailed the survey. The responses were collected anonymously. Results The response rate for this survey was 44% (177 responses/400 total members). Non-responders were characterized by the fact that multiple responders were not obtained from practices that had multiple providers with uniform practice. Both high-volume and low-volume centers were equally represented. Optimizing medical management is first-line treatment in practice. Although there is some variability regarding screening methods, the greatest variability occurs with regard to the choice of intra-arterial treatment drug and dose. There is also considerable variability in the perceived effectiveness of endovascular treatment for vasospasm. Conclusions In this preliminary glimpse of actual cerebral vasospasm management practice in the USA, two salient points emerge: (1) there is considerable variability in intra-arterial therapies for vasospasm; and (2) there are major differences in the perceived effectiveness of these therapies. Standardization of intra-arterial therapies may contribute to improved outcomes. A prospective randomized trial evaluating endovascular treatment for cerebral vasospasm is needed.